vs
Axogen, Inc.（AXGN）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是RBB Bancorp的1.9倍（$61.5M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -31.9%，领先63.4%），Axogen, Inc.同比增速更快（26.6% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-1.4M），过去两年Axogen, Inc.的营收复合增速更高（13.3% vs 7.0%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
AXGN vs RBB — 直观对比
营收规模更大
AXGN
是对方的1.9倍
$32.3M
营收增速更快
AXGN
高出14.0%
12.6%
净利率更高
RBB
高出63.4%
-31.9%
自由现金流更多
RBB
多$44.0M
$-1.4M
两年增速更快
AXGN
近两年复合增速
7.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.5M | $32.3M |
| 净利润 | $-19.6M | $10.2M |
| 毛利率 | 75.2% | — |
| 营业利润率 | 20.2% | 39.5% |
| 净利率 | -31.9% | 31.5% |
| 营收同比 | 26.6% | 12.6% |
| 净利润同比 | -410.8% | 132.1% |
| 每股收益（稀释后） | $-0.38 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNRBB
| Q1 26 | $61.5M | — | ||
| Q4 25 | $59.9M | $32.3M | ||
| Q3 25 | $60.1M | $32.6M | ||
| Q2 25 | $56.7M | $35.8M | ||
| Q1 25 | $48.6M | $28.5M | ||
| Q4 24 | $49.4M | $28.7M | ||
| Q3 24 | $48.6M | $30.3M | ||
| Q2 24 | $47.9M | $27.5M |
净利润AXGNRBB
| Q1 26 | $-19.6M | — | ||
| Q4 25 | $-13.2M | $10.2M | ||
| Q3 25 | $708.0K | $10.1M | ||
| Q2 25 | $579.0K | $9.3M | ||
| Q1 25 | $-3.8M | $2.3M | ||
| Q4 24 | $450.0K | $4.4M | ||
| Q3 24 | $-1.9M | $7.0M | ||
| Q2 24 | $-1.9M | $7.2M |
毛利率AXGNRBB
| Q1 26 | 75.2% | — | ||
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — |
营业利润率AXGNRBB
| Q1 26 | 20.2% | — | ||
| Q4 25 | -16.3% | 39.5% | ||
| Q3 25 | 3.2% | 40.7% | ||
| Q2 25 | 3.0% | 36.1% | ||
| Q1 25 | -3.4% | 11.2% | ||
| Q4 24 | 4.1% | 17.6% | ||
| Q3 24 | -0.6% | 31.6% | ||
| Q2 24 | -0.9% | 35.6% |
净利率AXGNRBB
| Q1 26 | -31.9% | — | ||
| Q4 25 | -22.0% | 31.5% | ||
| Q3 25 | 1.2% | 31.2% | ||
| Q2 25 | 1.0% | 26.1% | ||
| Q1 25 | -7.9% | 8.0% | ||
| Q4 24 | 0.9% | 15.3% | ||
| Q3 24 | -3.8% | 23.1% | ||
| Q2 24 | -4.0% | 26.4% |
每股收益（稀释后）AXGNRBB
| Q1 26 | $-0.38 | — | ||
| Q4 25 | $-0.28 | $0.59 | ||
| Q3 25 | $0.01 | $0.59 | ||
| Q2 25 | $0.01 | $0.52 | ||
| Q1 25 | $-0.08 | $0.13 | ||
| Q4 24 | $-0.00 | $0.26 | ||
| Q3 24 | $-0.04 | $0.39 | ||
| Q2 24 | $-0.04 | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.7M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $244.8M | $523.4M |
| 总资产 | $289.5M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资AXGNRBB
| Q1 26 | $82.7M | — | ||
| Q4 25 | $41.5M | $212.3M | ||
| Q3 25 | $35.8M | $234.9M | ||
| Q2 25 | $29.9M | $191.9M | ||
| Q1 25 | $22.1M | $238.8M | ||
| Q4 24 | $33.5M | $257.7M | ||
| Q3 24 | $24.5M | $349.4M | ||
| Q2 24 | $21.1M | $252.8M |
总债务AXGNRBB
| Q1 26 | — | — | ||
| Q4 25 | $48.4M | $119.9M | ||
| Q3 25 | $48.2M | $119.8M | ||
| Q2 25 | $47.9M | $119.7M | ||
| Q1 25 | $47.7M | $119.6M | ||
| Q4 24 | $47.5M | $119.5M | ||
| Q3 24 | $47.3M | $119.4M | ||
| Q2 24 | $47.0M | $119.3M |
股东权益AXGNRBB
| Q1 26 | $244.8M | — | ||
| Q4 25 | $128.8M | $523.4M | ||
| Q3 25 | $120.8M | $514.3M | ||
| Q2 25 | $112.3M | $517.7M | ||
| Q1 25 | $105.4M | $510.3M | ||
| Q4 24 | $103.9M | $507.9M | ||
| Q3 24 | $99.4M | $509.7M | ||
| Q2 24 | $95.7M | $511.3M |
总资产AXGNRBB
| Q1 26 | $289.5M | — | ||
| Q4 25 | $221.7M | $4.2B | ||
| Q3 25 | $216.4M | $4.2B | ||
| Q2 25 | $205.5M | $4.1B | ||
| Q1 25 | $196.2M | $4.0B | ||
| Q4 24 | $203.7M | $4.0B | ||
| Q3 24 | $192.0M | $4.0B | ||
| Q2 24 | $188.9M | $3.9B |
负债/权益比AXGNRBB
| Q1 26 | — | — | ||
| Q4 25 | 0.38× | 0.23× | ||
| Q3 25 | 0.40× | 0.23× | ||
| Q2 25 | 0.43× | 0.23× | ||
| Q1 25 | 0.45× | 0.23× | ||
| Q4 24 | 0.46× | 0.24× | ||
| Q3 24 | 0.48× | 0.23× | ||
| Q2 24 | 0.49× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.4M | $42.6M |
| 自由现金流率自由现金流/营收 | -2.3% | 131.8% |
| 资本支出强度资本支出/营收 | — | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $9.1M | $73.5M |
8季度趋势，按日历期对齐
经营现金流AXGNRBB
| Q1 26 | — | — | ||
| Q4 25 | $3.0M | $43.4M | ||
| Q3 25 | $3.2M | $2.1M | ||
| Q2 25 | $7.7M | $21.7M | ||
| Q1 25 | $-13.2M | $7.8M | ||
| Q4 24 | $8.7M | $58.5M | ||
| Q3 24 | $3.9M | $24.5M | ||
| Q2 24 | $4.2M | $11.7M |
自由现金流AXGNRBB
| Q1 26 | $-1.4M | — | ||
| Q4 25 | $1.8M | $42.6M | ||
| Q3 25 | $1.7M | $1.8M | ||
| Q2 25 | $7.0M | $21.6M | ||
| Q1 25 | $-13.4M | $7.6M | ||
| Q4 24 | $8.1M | $57.7M | ||
| Q3 24 | $3.3M | $24.2M | ||
| Q2 24 | $3.3M | $11.5M |
自由现金流率AXGNRBB
| Q1 26 | -2.3% | — | ||
| Q4 25 | 3.0% | 131.8% | ||
| Q3 25 | 2.8% | 5.4% | ||
| Q2 25 | 12.4% | 60.2% | ||
| Q1 25 | -27.7% | 26.7% | ||
| Q4 24 | 16.3% | 201.0% | ||
| Q3 24 | 6.8% | 80.0% | ||
| Q2 24 | 6.8% | 42.0% |
资本支出强度AXGNRBB
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 2.5% | ||
| Q3 25 | 2.5% | 1.1% | ||
| Q2 25 | 1.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.6% | ||
| Q4 24 | 1.4% | 2.7% | ||
| Q3 24 | 1.2% | 0.8% | ||
| Q2 24 | 1.9% | 0.5% |
现金转化率AXGNRBB
| Q1 26 | — | — | ||
| Q4 25 | — | 4.26× | ||
| Q3 25 | 4.55× | 0.21× | ||
| Q2 25 | 13.35× | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | 19.41× | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
